Guest guest Posted September 28, 2005 Report Share Posted September 28, 2005 http://my.webmd.com/content/article/112/110505.htm " ....The FDA is also conducting a review of reports of psychotic episodes and suicidal thoughts in patients taking Concerta, a brand-name form of methylphenidate. " The agency declined several months ago to alter the drug's label to warn of the risks but is withholding a final decision until its review is complete. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.